Atazanavir and cobicistat and Cafcit Oral
Determining the interaction of Atazanavir and cobicistat and Cafcit Oral and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:According to the product labeling, clinically significant interactions are not expected between atazanavir and substrates of CYP450 1A2, 2A6, 2B6, 2C19, 2C9, 2D6, or 2E1. No particular precaution or dosage adjustment should be necessary.
- "Product Information. Reyataz (atazanavir)." Bristol-Myers Squibb, Princeton, NJ.
Generic Name: atazanavir / cobicistat
Brand name: Evotaz
Synonyms: Atazanavir and Cobicistat
Generic Name: caffeine
Brand name: Cafcit, NoDoz, Vivarin
Synonyms: Cafcit
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Atazanavir and cobicistat-Cafergot (Ergotamine and Caffeine Suppositories)
- Atazanavir and cobicistat-Cafergot (Ergotamine and Caffeine Tablets)
- Atazanavir and cobicistat-Cafergot Tablets
- Atazanavir and cobicistat-Caffeine
- Atazanavir and cobicistat-Caffeine and ergotamine oral/rectal
- Atazanavir and cobicistat-Caffeine and sodium benzoate Injection
- Cafcit Oral-Atazanavir Capsules
- Cafcit Oral-Atazanavir Powder for Oral Suspension
- Cafcit Oral-Atazanavir Sulfate
- Cafcit Oral-Atelvia
- Cafcit Oral-Atendia Patch
- Cafcit Oral-Atenolol